Completed PHASE3 INTERVENTIONAL 1-arm NCT01083797

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate: a Comparative Study of the Qualitative and Quantitative Electroencephalogram Pattern

Sponsor: Federal University of Minas Gerais

Conditions Other Conditions of Brain

Interventions Chloral Hydrate Dexmedetomidine

Updated 5 times since 2017 Last updated: Oct 24, 2013 Started: Dec 31, 2009 Primary completion: Mar 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01083797, this PHASE3 trial focuses on Other Conditions of Brain and remains completed. Sponsored by Federal University of Minas Gerais, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal University of Minas Gerais
Santa Casa de Misericórdia de Belo Horizonte

Data source: Federal University of Minas Gerais

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belo Horizonte, Brazil